Skip to main content
Chison Medical Technologies Co.,Ltd. logo

Chison Medical Technologies Co.,Ltd. — Investor Relations & Filings

Ticker · 688358 ISIN · CNE1000076R4 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 686 across all filing types
Latest filing 2019-12-25 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688358

About Chison Medical Technologies Co.,Ltd.

https://www.chison.com/

Chison Medical Technologies Co.,Ltd. specializes in the research, development, and manufacturing of diagnostic ultrasound systems. The company offers a comprehensive portfolio of medical imaging solutions, including trolley-based color Doppler systems, portable ultrasound units, and specialized handheld devices. Its products integrate advanced imaging technologies such as 4D imaging, artificial intelligence-assisted diagnostics, and high-resolution transducers to support clinical applications in cardiology, obstetrics, gynecology, and point-of-care settings. Chison focuses on delivering high-performance diagnostic tools to healthcare providers, supported by a global network of research centers and distribution channels. The company emphasizes continuous innovation in digital signal processing and transducer technology to enhance diagnostic accuracy and clinical workflow efficiency.

Recent filings

Filing Released Lang Actions
第一届监事会第八次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of resolutions passed at the eighth meeting of the first Supervisory Board of Wuxi Xiangsheng Medical Technology Co., Ltd. It details the meeting procedures, voting results, and approvals related to the use of raised funds, a 2019 restricted stock incentive plan draft, its implementation assessment methods, and verification of incentive recipients. The document is an official meeting resolution announcement rather than a full report or financial statement. It does not contain financial data or detailed financial analysis but rather governance and supervisory board decisions. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2019-12-25 Chinese
监事会关于公司2019年限制性股票激励计划（草案）的核查意见
Governance Information Classification · 95% confidence The document is a supervisory board's verification opinion on the company's 2019 restricted stock incentive plan draft. It discusses compliance with laws and regulations related to stock incentive plans, eligibility of incentive recipients, and the plan's alignment with company and regulatory requirements. There is no financial data, earnings information, or report publication announcement. The content focuses on governance and regulatory compliance regarding a stock incentive plan, which fits best under Governance Information (CGR). The document length is short and it is not an announcement of a report but a formal opinion on governance matters.
2019-12-25 Chinese
关于独立董事公开征集委托投票权的公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a public announcement by an independent director soliciting proxy voting rights for a specific upcoming shareholders' meeting. It details the voting period, the agenda items related to a restricted stock incentive plan, the procedures for submitting proxy authorizations, and the independent director's voting opinions. There are no financial statements, earnings data, or comprehensive report content. The document is focused on the solicitation of voting rights and proxy instructions for a shareholder meeting, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA). However, since it is a solicitation of proxy votes rather than the announcement of voting results, it is more accurately classified as a Proxy Solicitation & Information Statement (PSI). The document length is about 4,836 characters, which is consistent with a detailed proxy solicitation notice rather than a full report or a brief announcement. Therefore, the best classification is PSI.
2019-12-25 Chinese
2019年限制性股票激励计划法律意见书
Regulatory Filings
2019-12-25 Chinese
关于使用募集资金置换预先投入募投项目及已支付发行费用的自筹资金的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Wuxi Xiangsheng Medical Technology Co., Ltd. regarding the use of raised funds to replace self-raised funds previously invested in projects and paid issuance expenses. It details the board and supervisory approvals, independent director opinions, and auditor verification reports related to the use of proceeds from a recent IPO. The document includes specific financial figures about the raised funds, their allocation, and compliance with regulatory requirements. It is not a full financial report like an Annual Report or Interim Report, nor is it a simple announcement of a report publication. Instead, it is a regulatory announcement about capital use and compliance with fundraising regulations. This fits best under Capital/Financing Update (CAP) as it concerns the use and replacement of capital raised through financing activities.
2019-12-25 Chinese
关于召开2020年第二次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice about convening the 2020 second extraordinary general meeting of shareholders for Wuxi Xiangsheng Medical Technology Co., Ltd. It includes details about the meeting date, voting methods, agenda items, and proxy authorization. There is no financial data, earnings, or report content. It is an announcement related to a shareholders meeting, specifically a notice to shareholders about the meeting and voting procedures. This fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings. The document length is 3195 characters, which is relatively short and consistent with a meeting notice rather than a full report.
2019-12-25 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.